A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy
Condition(s) studied
Investigational drug(s) / intervention(s)
Shape-Sensing Robotic-Assisted Bronchoscopy with Cone-Beam CT (ssRAB with CBCT): A bronchoscopic lung nodule biopsy procedure performed using shape-sensing robotic-assisted bronchoscopy with cone-beam CT guidance as clinically indicated and according to standard clinical practice.
CT-guided percutaneous lung nodule biopsy: A percutaneous lung nodule biopsy procedure performed under CT imaging guidance according to standard clinical practice.
Study summary
The ENCOMPASS study is a post-market, multicenter, randomized controlled trial comparing two established approaches for obtaining a biopsy of small pulmonary nodules (≤2 cm): CT-guided percutaneous lung nodule biopsy and shape-sensing robotic-assisted bronchoscopy with cone-beam CT (ssRAB with CBCT).
Eligibility
Primary outcome measure(s)
- Diagnostic Efficacy of the Assigned Biopsy Procedure — At the index procedure
Diagnostic efficacy will be calculated as the proportion of patients who receive their assigned treatment multiplied by diagnostic yield of their assigned treatment. - Peri-Procedural Pneumothorax Rate — From procedure to 7 days (or until subsequent intervention, whichever occurs first).
Rate of peri-procedural pneumothorax related to the assigned index biopsy procedure, including pneumothorax identified on routine post-procedure imaging and clinically relevant pneumothorax requiring intervention or escalation of care.
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| Thoraxklinik Heidelberg | Heidelberg | Germany | Recruiting |
| Basel University Hospital | Basel | Canton of Basel-City | Recruiting |
| University College London Hospitals NHS Foundation | London | United Kingdom | Recruiting |
More Intuitive Surgical trials in the UK
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07761351 on ClinicalTrials.gov ↗ ← All trials in the UK